Author

Mi Wang

Tongji Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:ChIP-seq· 1 Approach:experimental assay· 1 Approach:large language model· 1 Approach:machine learning (classical)· 1 Organism:mouse· 1

Frequent Co-Authors

Abhijit ParoliaiD· 1 shared Abigail J. ToddiD· 1 shared Alexandra K. MouraiD· 1 shared Arul M. ChinnaiyaniD· 1 shared Arvind RaoiD· 1 shared Dan WangiD· 1 shared Eleanor Young· 1 shared Fengyun SuiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhijit ParoliaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Rewiring Oncogenic Transcriptional Complexes with Domain-ALTerAtion Chimeras (DALTACs) in Prostate Cancer

Jie Luo, Jianzhang Yang, Jean Ching-Yi Tien, Mi Wang, Sumit Das, Xiaoju Wang, Eleanor Young, Jelena Tošović, Rahul Mannan, Weiguo Xiang, Xia Jiang, Jocelyn Cai, Yihan Liu, Kenneth Gu, Somnath Mahapatra, , Arul M. Chinnaiyan

A bifunctional AR–p300/CBP molecule, DALTAC-1, forces a non-native contact between AR and p300 domains, silences AR enhancers and regresses AR-driven prostate tumors in mice while sparing AR-negative lines.

bioRxiv · Sep 24, 2026 · PreprintCancer Biology✦ In-depth digest

An LSEC-focused computational drug repurposing platform for liver fibrosis: Identification of vorinostat and other LSEC-protective candidates

Rui Zuo, Mi Wang, Y Q Wang, Jenny Z. Hu, Alexandra K. Moura, Dan Wang, Pin-Lan Li, Mingfu Wu, Tahir Hussain, Wei Gao, Xiang Li, Yang Zhang

This paper develops a computational platform to repurpose drugs for liver fibrosis by focusing on LSECs, identifying vorinostat and other candidates that protect LSECs.

bioRxiv · May 27, 2026 · PreprintPharmacology & Toxicology